AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

NASDAQ:MYOKMyokardia News Headlines

$103.26
-0.72 (-0.69 %)
(As of 06/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$101.87
Now: $103.26
$104.83
50-Day Range
$52.58
MA: $81.62
$121.69
52-Week Range
$42.65
Now: $103.26
$126.30
Volume247,498 shs
Average Volume614,045 shs
Market Capitalization$4.82 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.33

Headlines

Myokardia (NASDAQ MYOK) News Headlines

Source:
DateHeadline
MyoKardia, Inc. (MYOK): Hedge Funds Are Snapping Up - Yahoo FinanceMyoKardia, Inc. (MYOK): Hedge Funds Are Snapping Up - Yahoo Finance
finance.yahoo.com - June 2 at 10:14 PM
MyoKardia, Inc. (MYOK): Hedge Funds Are Snapping UpMyoKardia, Inc. (MYOK): Hedge Funds Are Snapping Up
finance.yahoo.com - June 2 at 10:14 PM
Myokardia Inc (NASDAQ:MYOK) Receives Consensus Recommendation of "Buy" from AnalystsMyokardia Inc (NASDAQ:MYOK) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 2 at 2:37 PM
Financial Contrast: TFF Pharmaceuticals (NASDAQ:TFFP) & Myokardia (NASDAQ:MYOK)Financial Contrast: TFF Pharmaceuticals (NASDAQ:TFFP) & Myokardia (NASDAQ:MYOK)
www.americanbankingnews.com - May 23 at 6:46 PM
Myokardias (MYOK) Overweight Rating Reiterated at Cantor FitzgeraldMyokardia's (MYOK) Overweight Rating Reiterated at Cantor Fitzgerald
www.americanbankingnews.com - May 20 at 9:31 AM
Myokardias (MYOK) "Overweight" Rating Reaffirmed at Cantor FitzgeraldMyokardia's (MYOK) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
www.marketbeat.com - May 20 at 8:57 AM
-$1.53 Earnings Per Share Expected for Myokardia Inc (NASDAQ:MYOK) This Quarter-$1.53 Earnings Per Share Expected for Myokardia Inc (NASDAQ:MYOK) This Quarter
www.americanbankingnews.com - May 20 at 7:45 AM
Myokardia Inc (NSQ:MYOK) price about to hit new 52-week highMyokardia Inc (NSQ:MYOK) price about to hit new 52-week high
uk.finance.yahoo.com - May 18 at 8:45 AM
Should You Buy MyoKardia Stock After This Week’s 96% Gain? - Motley FoolShould You Buy MyoKardia Stock After This Week’s 96% Gain? - Motley Fool
www.fool.com - May 16 at 7:18 AM
Should You Buy MyoKardia Stock After This Week’s 96% Gain?Should You Buy MyoKardia Stock After This Week’s 96% Gain?
finance.yahoo.com - May 16 at 7:18 AM
Building toward FDA drug approval, Peninsula biotech targets $605M stock offering - San Francisco Business TimesBuilding toward FDA drug approval, Peninsula biotech targets $605M stock offering - San Francisco Business Times
www.bizjournals.com - May 15 at 6:14 AM
MyoKardia prices stock offering at $105MyoKardia prices stock offering at $105
seekingalpha.com - May 14 at 12:47 PM
Myokardia (NASDAQ:MYOK) Price Target Increased to $148.00 by Analysts at BMO Capital MarketsMyokardia (NASDAQ:MYOK) Price Target Increased to $148.00 by Analysts at BMO Capital Markets
www.americanbankingnews.com - May 14 at 12:22 PM
Wedbush Weighs in on Myokardia Incs Q2 2020 Earnings (NASDAQ:MYOK)Wedbush Weighs in on Myokardia Inc's Q2 2020 Earnings (NASDAQ:MYOK)
www.americanbankingnews.com - May 14 at 11:32 AM
Anastasios Gianakakos Sells 25,000 Shares of Myokardia Inc (NASDAQ:MYOK) StockAnastasios Gianakakos Sells 25,000 Shares of Myokardia Inc (NASDAQ:MYOK) Stock
www.marketbeat.com - May 13 at 5:32 PM
Why MyoKardias Stock Is Trading Higher Today - BenzingaWhy MyoKardia's Stock Is Trading Higher Today - Benzinga
www.benzinga.com - May 13 at 6:43 AM
MyoKardia (MYOK) Joins $100 Stock Price Club - NasdaqMyoKardia (MYOK) Joins $100 Stock Price Club - Nasdaq
www.nasdaq.com - May 12 at 8:20 PM
Wedbush Raises Myokardia (NASDAQ:MYOK) Price Target to $127.00Wedbush Raises Myokardia (NASDAQ:MYOK) Price Target to $127.00
www.americanbankingnews.com - May 12 at 4:12 PM
Myokardia (NASDAQ:MYOK) Price Target Increased to $125.00 by Analysts at CitigroupMyokardia (NASDAQ:MYOK) Price Target Increased to $125.00 by Analysts at Citigroup
www.americanbankingnews.com - May 12 at 3:39 PM
MyoKardia Reaches Analyst Target Price - NasdaqMyoKardia Reaches Analyst Target Price - Nasdaq
www.nasdaq.com - May 12 at 3:20 PM
First Week of December 18th Options Trading For MyoKardia (MYOK) - NasdaqFirst Week of December 18th Options Trading For MyoKardia (MYOK) - Nasdaq
www.nasdaq.com - May 12 at 3:20 PM
Why MyoKardia (MYOK) Stock Could Rise Another 30% - Yahoo Finance AustraliaWhy MyoKardia (MYOK) Stock Could Rise Another 30% - Yahoo Finance Australia
finance.yahoo.com - May 12 at 3:20 PM
Company News for May 12, 2020Company News for May 12, 2020
finance.yahoo.com - May 12 at 3:20 PM
Why MyoKardia (MYOK) Stock Could Rise Another 30%Why MyoKardia (MYOK) Stock Could Rise Another 30%
finance.yahoo.com - May 12 at 3:20 PM
Peninsula heart drug maker soars on positive late-stage clinical trial - San Francisco Business TimesPeninsula heart drug maker soars on positive late-stage clinical trial - San Francisco Business Times
www.bizjournals.com - May 11 at 10:40 PM
MyoKardia Announces Proposed Public Offering of Common StockMyoKardia Announces Proposed Public Offering of Common Stock
finance.yahoo.com - May 11 at 10:40 PM
Is the Options Market Predicting a Spike in MyoKardia (MYOK) Stock? - Yahoo FinanceIs the Options Market Predicting a Spike in MyoKardia (MYOK) Stock? - Yahoo Finance
finance.yahoo.com - May 11 at 5:39 PM
MyoKardia Surges After Heart Drug Clears Late-Stage Hurdle - BloombergMyoKardia Surges After Heart Drug Clears Late-Stage Hurdle - Bloomberg
www.bloomberg.com - May 11 at 5:39 PM
MyoKardia Surges After Heart Drug Clears Late-Stage HurdleMyoKardia Surges After Heart Drug Clears Late-Stage Hurdle
finance.yahoo.com - May 11 at 5:39 PM
Why MyoKardia Stock Is on Fire TodayWhy MyoKardia Stock Is on Fire Today
finance.yahoo.com - May 11 at 5:39 PM
Is the Options Market Predicting a Spike in MyoKardia (MYOK) Stock?Is the Options Market Predicting a Spike in MyoKardia (MYOK) Stock?
finance.yahoo.com - May 11 at 5:39 PM
Myokardia (NASDAQ:MYOK) Price Target Raised to $136.00Myokardia (NASDAQ:MYOK) Price Target Raised to $136.00
www.americanbankingnews.com - May 11 at 5:28 PM
Myokardia (NASDAQ:MYOK) Price Target Raised to $145.00 at CowenMyokardia (NASDAQ:MYOK) Price Target Raised to $145.00 at Cowen
www.americanbankingnews.com - May 11 at 5:28 PM
Stock Traders Buy High Volume of Myokardia Call Options (NASDAQ:MYOK)Stock Traders Buy High Volume of Myokardia Call Options (NASDAQ:MYOK)
www.americanbankingnews.com - May 11 at 11:52 AM
Wedbush Weighs in on Myokardia Incs FY2024 Earnings (NASDAQ:MYOK)Wedbush Weighs in on Myokardia Inc's FY2024 Earnings (NASDAQ:MYOK)
www.americanbankingnews.com - May 11 at 5:34 AM
MyoKardia Reports First Quarter 2020 Financial Results Nasdaq:MYOK - GlobeNewswireMyoKardia Reports First Quarter 2020 Financial Results Nasdaq:MYOK - GlobeNewswire
www.globenewswire.com - May 7 at 4:21 PM
MyoKardia Reports First Quarter 2020 Financial ResultsMyoKardia Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 7 at 4:21 PM
Unproven Upside Potential For MyoKardias Mavacamten - Seeking AlphaUnproven Upside Potential For MyoKardia's Mavacamten - Seeking Alpha
seekingalpha.com - May 4 at 4:41 PM
Kim Popovits says she retired after the $3 billion sale of Genomic Health. Dont believe her. - Bizwomen - New York Business JournalKim Popovits says she retired after the $3 billion sale of Genomic Health. Don't believe her. - Bizwomen - New York Business Journal
www.bizjournals.com - April 28 at 3:53 AM
Kim Popovits says she retired after the $3 billion sale of Genomic Health. Dont believe her. - Bizwomen - The Business JournalsKim Popovits says she retired after the $3 billion sale of Genomic Health. Don't believe her. - Bizwomen - The Business Journals
www.bizjournals.com - April 27 at 5:52 PM
Bullish Two Hundred Day Moving Average Cross - MYOK - NasdaqBullish Two Hundred Day Moving Average Cross - MYOK - Nasdaq
www.nasdaq.com - April 17 at 7:36 PM
Are Options Traders Betting on a Big Move in MyoKardia (MYOK) Stock? - Yahoo FinanceAre Options Traders Betting on a Big Move in MyoKardia (MYOK) Stock? - Yahoo Finance
finance.yahoo.com - April 8 at 12:51 PM
Are Options Traders Betting on a Big Move in MyoKardia (MYOK) Stock? - NasdaqAre Options Traders Betting on a Big Move in MyoKardia (MYOK) Stock? - Nasdaq
www.nasdaq.com - April 7 at 5:48 PM
Should You Buy These 3 Biotechs Now? - Motley FoolShould You Buy These 3 Biotechs Now? - Motley Fool
www.fool.com - April 3 at 12:02 PM
MyoKardia Announces Mavacamten Treatment Well Tolerated and Significantly Reduced Biomarkers of Cardiac Injury and Wall Stress in Non-Obstructive Hypertrophic Cardiomyopathy PatientsMyoKardia Announces Mavacamten Treatment Well Tolerated and Significantly Reduced Biomarkers of Cardiac Injury and Wall Stress in Non-Obstructive Hypertrophic Cardiomyopathy Patients
finance.yahoo.com - March 30 at 6:08 PM
MyoKardia (MYOK) Reports Clinical Trial Update in Context of COVID-19 Pandemic - StreetInsider.comMyoKardia (MYOK) Reports Clinical Trial Update in Context of COVID-19 Pandemic - StreetInsider.com
www.streetinsider.com - March 27 at 6:05 PM
Hedge Funds Were Buying MyoKardia, Inc. (MYOK) Before The Coronavirus - Yahoo FinanceHedge Funds Were Buying MyoKardia, Inc. (MYOK) Before The Coronavirus - Yahoo Finance
finance.yahoo.com - March 27 at 6:05 PM
MyoKardia Provides Clinical Trial Update in the Context of the COVID-19 Pandemic - Yahoo FinanceMyoKardia Provides Clinical Trial Update in the Context of the COVID-19 Pandemic - Yahoo Finance
finance.yahoo.com - March 27 at 6:05 PM
BRIEF-Myokardia Says Studies Planned To Initiate In Q2 Will Be Delayed Until Conditions ChangeBRIEF-Myokardia Says Studies Planned To Initiate In Q2 Will Be Delayed Until Conditions Change
www.reuters.com - March 27 at 1:05 PM
Hedge Funds Were Buying MyoKardia, Inc. (MYOK) Before The CoronavirusHedge Funds Were Buying MyoKardia, Inc. (MYOK) Before The Coronavirus
finance.yahoo.com - March 27 at 1:04 PM
This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.